The Clinical Trial Application sent to the MHRA is for a combination drug with the potential to become a cost-effective treatment against early Alzheimer’s disease.
List view / Grid view
UK Medicines and Healthcare Regulatory Agency (MHRA)
European Pharmaceutical Review explores how a surge in the number of warning letters for data integrity failings have prompted regulators to publish new guidelines.
The UK healthcare agency has issued an alert for Perrigo ranitidine products, recalling and quarantining certain batches.